Seshasayee (Sesha) Varadarajan
About Seshasayee (Sesha) Varadarajan
Senior Vice President, Global Products Group at Lam Research since March 2023; age 50 as of August 7, 2025. Education: M.S. in manufacturing engineering and material science (Boston University), B.S. in mechanical engineering (University of Mysore). Longstanding deposition and PECVD/Electrofill leadership across Novellus and Lam since 1999. Company performance context during his tenure: Lam revenue ~$16.2B in CY2024 (+13% YoY), operating cash flow ~$4.6B and ~$1.1B dividends; March+June 2025 combined revenue ~$9.9B and OCF ~$3.9B; Say-on-Pay support exceeded 90% from 2021–2024 .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Lam Research | SVP, Global Products Group | Mar 2023–present | Oversees product portfolio integration and execution across product groups . |
| Lam Research | SVP & GM, Deposition BU | Feb 2018–Mar 2023 | Led deposition business unit operations and market execution . |
| Lam Research | Group VP, Deposition Product Group | Sep 2013–Feb 2018 | Scaled deposition portfolio post-Novellus integration . |
| Lam Research | Head, PECVD/Electrofill BU | Jun 2012–Sep 2013 | Drove PECVD/electrofill technology and business leadership following Novellus acquisition . |
| Novellus Systems | SVP & GM, PECVD & Electrofill BUs | 2011–Jun 2012 | Led twin BU strategy and P&L prior to Lam acquisition . |
| Novellus Systems | VP & GM, Electrofill BU | 2009–2011 | Drove product and market execution for electrofill . |
| Novellus Systems | PECVD BU: Director → Product GM | 2006–2008 | Advanced PECVD technology development and product management . |
| Novellus Systems | Director of Technology, Electrofill BU | 2004–2006 | Led technology development roadmap . |
| Novellus Systems | Process Engineer, Electrofill BU | 1999–2004 | Early technical leadership in copper electrofill processes . |
External Roles
No public-company board service disclosed for Varadarajan in Lam’s executive officer listings and proxy materials .
Fixed Compensation
| Metric | 2024 | 2025 |
|---|---|---|
| Annual Base Salary ($) | $685,000 | $766,000 |
Multi-year compensation (fiscal basis):
| Metric | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Salary ($) | $537,151 | $561,697 | $714,596 |
| Bonus ($) | $6,400 | $2,800 | $2,560 |
| Stock Awards ($) | $2,603,133 | $4,528,866 | $5,609,261 |
| Option Awards ($) | $520,842 | $857,469 | — |
| Non-Equity Incentive ($) | $516,739 | $649,805 | $838,646 |
| All Other Compensation ($) | $9,312 | $12,684 | $15,789 |
| Total ($) | $4,193,577 | $6,613,321 | $7,180,852 |
Performance Compensation
Annual Incentive Program (AIP) – CY2024 parameters and payout (SVP)
| Component | Target / Design | Actual Result (Factor) | Payout Detail |
|---|---|---|---|
| Target Award Opportunity | 100% of base salary ($685,000) | Funding Factor capped max at 250% of target | Actual payout: $838,646 |
| Corporate Performance Factor | Non-GAAP operating margin; equal weighting among performance factors | 1.06 | Applied to target |
| Profitability Performance Factor | Non-GAAP gross margin; equal weighting | 1.10 | Applied to target |
| Individual Performance Factor | Goals across market execution, safety/quality/customer, human capital, financial | 1.05 | Applied to target |
Design notes: In CY2024 the committee used equal weighting across Corporate and Profitability Performance Factors and AIP maintained a 2.50x cap via the Funding Factor; for CY2025, target percentages unchanged for SVPs (100%) and the committee reverted to linear metric-to-result relationships for simplicity .
Long-Term Incentive Program (LTIP)
CY2025/2027 design (SVPs): 55% Market-based PRSUs, 45% service-based RSUs; negative absolute TSR cap at 100% of target; PRSUs vest at 3-year cliff; RSUs vest 1/3 annually over 3 years .
| Item | CY2025 Grant (Feb 28, 2025) |
|---|---|
| Target LTIP Award Opportunity ($) | $5,650,000 |
| Market-based PRSUs (# at target) | 38,199 (Performance period Feb 3, 2025–Feb 2, 2028) |
| Service-based RSUs (#) | 31,253 |
| PRSU Payout Scale (XSOX percentile rank) | 25th=50%, 50th=100%, 75th=150%; capped at 100% if absolute TSR <0 |
Outstanding awards at FY2025 year-end (market value at $97.20 close):
| Grant Type | Grant Date | Unvested/Unearned (#) | Market/Payout Value ($) |
|---|---|---|---|
| Service-based RSUs | 2/28/2025 | 31,253 | $3,037,792 |
| Market-based PRSUs (target) | 2/28/2025 | 38,199 | $3,712,943 |
| Service-based RSUs | 3/1/2024 | 10,620 | $1,032,264 |
| Market-based PRSUs (target) | 3/1/2024 | 29,190 | $2,837,268 |
| Service-based RSUs | 3/1/2023 | 6,540 | $635,688 |
| Market-based PRSUs (target) | 3/1/2023 | 35,950 | $3,494,340 |
Historical market-PRSUs payout for CY2022/2024 program: 56.94% of target (Lam underperformed XSOX by 21.53% over period) → Sesha earned 14,542 PRSUs vs 25,540 target .
Stock options: 2025 LTIP eliminated options; prior awards outstanding include (exercisable/unexercisable, price, expiry): 3/1/2024: 7,960/15,920 @ $98.15, exp. 3/1/2031; 3/1/2023: 19,600/9,800 @ $49.09, exp. 3/1/2030; 3/1/2022: 20,880 @ $54.06, exp. 3/1/2029; 3/1/2021: 12,270 @ $59.88, exp. 3/1/2028; 3/2/2020: 27,480 @ $30.03, exp. 3/2/2027 .
Insider selling pressure indicators (FY2025): Options exercised 110,080 shares; value realized $7,913,904; RSUs/PRSUs vested 31,032 shares; value realized $2,381,396 .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Beneficial Ownership (shares) | 237,783 |
| % of Shares Outstanding | ~0.019% (237,783 / 1,261,032,300 shares outstanding) |
| Near-term vesting within 60 days (options exercisable + RSUs vesting) | 88,190 shares |
| Ownership Guidelines | SVPs: 1x base salary; all NEOs in compliance or within allowed window |
| Hedging/Pledging | Prohibited by policy; exceptions only for diversified exchange funds capped at 2% Lam stock exposure |
Vested vs unvested snapshot (FY2025): Unvested RSUs total ~48,413 (31,253 + 10,620 + 6,540) ; Unearned PRSUs at target total ~103,339 (38,199 + 29,190 + 35,950) .
Employment Terms
| Provision | Key Terms |
|---|---|
| Role tenure | SVP, Global Products Group since March 2023 |
| Base salary | $766,000 effective Feb 17, 2025; $685,000 effective May 27, 2024 |
| Target bonus | 100% of base salary (SVP) for CY2024/CY2025 |
| Severance (general) | Executive severance policy applies; designated payments for involuntary termination, death/disability |
| Change-in-Control (CIC) | Double-trigger; cash equals 150% of base salary + 150% of five-year avg STI + pro rata STI; accelerated vesting of service-based equity; PRSUs convert to cash per formula; health benefit continuation; requires adherence to confidentiality & non-compete; non-solicit 6 months; release required |
| CIC economics (Sesha, illustrative as of 6/29/2025) | Severance $1,149,000; STI (5-year avg) $1,006,173; pro rata STI $279,493; accelerate options $471,458; RSUs $4,705,744; PRSUs $10,305,824; COBRA $49,845; total $17,967,537 |
| Clawback | Dodd-Frank/Nasdaq-compliant recoupment (effective 2023) for incentive-based comp on financial metrics; applies regardless of fault; prior 2014 policy superseded for comp received on/after Oct 2, 2023 |
| Tax gross-ups | None for perquisites or CIC; limited gross-ups only for relocation/anniversary awards generally available to employees |
| Option repricing | Prohibited without stockholder approval |
Investment Implications
- Pay-for-performance alignment: AIP tied to non-GAAP operating and gross margins with equal weighting and capped funding; LTIP uses relative TSR percentile with a cap when absolute TSR is negative—strong linkage to shareholder returns and profitability .
- Retention risk: Low near-term given substantial unvested RSUs ($3.04M) and PRSUs at target ($3.71M) from 2025 grants plus additional outstanding awards across 2023–2024; service RSUs vest annually and PRSUs cliff-vest, encouraging multi-year retention .
- Selling pressure: FY2025 option exercises (110,080 shares; $7.9M realized) indicate past monetization; remaining option inventory and scheduled RSU vesting can create ongoing supply, but hedging/pledging are prohibited and ownership guidelines promote alignment .
- Governance and investor signals: No CIC gross-ups, robust clawback, and repricing prohibitions reduce red flags. Strong Say-on-Pay support (>90% in 2021–2024) suggests investor confidence in compensation design .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks